Farmaciya (Pharmacy)

Peer-review scientific and practical medical journal

Editor-in-chief

  • Irina A. Samylina, Doctor of of Pharmaceutical Sciences, Corresponding Member of the RAS

Publisher

  • Publishing House «Russkiy Vrach»

Founder

  • Ministry of Health of the Russian Federation

  • Russian Center for Pharmaceutical and Medical-Technical Information

About

“Farmaciya” (Pharmacy) is a journal that publishes the results of researches in all areas of modern pharmacy. It analyzes problems in the standardization of both synthetic and natural medicaments and in the elaboration of current normative documents assuring the high quality of drugs and gives the latest data on procedures developed to determine them in biological fluids. The journal covers in detail the issues of technology aimed at preparing original agents, including those using nanotechnologies, the translation of ex tempore formulations to industrial production, and the results of pharmacoeconomic and pharmacological studies conducted in both animal experiments and clinical settings.

According to the Decision of the Presidium of the Higher Attestation Commission (HAC) the journal "Farmaciya" is included into the list of leading peer-reviewed scientific journals, in which the main results of the thesis for the degree of doctor and candidate of sciences should be published. Journal "Farmaciya" is included in the Russian Science Citation Index.

According to the data of the Scientific Electronic Library eLIBRARY.RU as of February 20, 2014, RISC (Russian Index of Scientific Citation) impact factor of the journal "Farmaciya" amounted to 0,325


Sections

  • Pharmaceutical chemistry and pharmacognosy
  • Organization and economy
  • Technology of medicines
  • Pharmacology: Experiment and clinic
  • Current information
  • Competent opinion
  • Education
  • Homeopathy
  • Literature review

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription Access

Vol 74, No 8 (2025)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Review

Modern approaches to the study of phenolic compounds of medicinal plant raw materials
Radimich A.I., Saybel O.L., Dargaeva T.D., Rendyuk T.D.
Abstract

Introduction. Phenolic compounds are a group of secondary metabolites characterized by a significant variety of structures and biological activity. These substances are widely distributed among plants and are the subject of many studies aimed at the search and development of new medicines and preventive products.

The purpose of this work is to summarize and analyze literature data on modern methods of extraction, separation, identification of phenolic compounds, as well as their qualitative and quantitative analysis. According to the literature, maceration and circulating extraction are used for the extraction of phenolic compounds, as well as alternative methods such as ultrasound-assisted extraction, microwave-assisted extraction, supercritical fluid extraction, enzyme-assisted extraction, accelerated solvent extraction and extraction using high-voltage electric discharges.

Material and methods. Such methods as liquid-liquid extraction, solid-phase extraction, precipitation, centrifugation, filtration (micro-, ultra- and nanofiltration), crystallization and various chromatographic methods are used for purification and separation of substances. The identification of phenolic compounds is based on the determination of their physico-chemical characteristics obtained by NMR-spectroscopy, UV-, IR-, and mass spectrometry. In the qualitative and quantitative analysis of phenolic compounds, the use of high-performance liquid chromatography in combination with diode array detection and mass spectrometric detection shows the greatest efficiency. To assess the total content of phenolic compounds, a spectrophotometric method is used based on their interaction with Folin–Denis or Folin–Chocolteu reagents, and for flavonoids with an aluminum chloride solution.

Conclusion. Thus, modern phytochemical studies have a significant arsenal of extraction, separation and analysis methods that make it possible to efficiently and reliably determine the composition and content of phenolic compounds in plant raw materials. At the same time, despite the high informative value of the methods currently used, the fundamental stage of phytochemical research remains the development of an experimental methodology determined by the specifics of the structure and properties of the substances being determined, as well as related components.

Farmaciya (Pharmacy). 2025;74(8):5-13
pages 5-13 views

Pharmaceutical chemistry and pharmacognosy

Identification of the red and panther fly agaric for laboratory diagnosis of poisoning
Evdokimova E.A., Goncharov M.Y., Balabanova O.L., Strelova O.Y.
Abstract

Introduction. Mushrooms of the genus Amanita are found worldwide and comprise approximately 1000 species, 100 of which are considered poisonous. Interest in Amanita mushrooms has increased particularly in the past 3–5 years due to the popularity of “microdosing” fly agarics and the medicinal use of Amanita muscaria (Amanita muscaria L.) and Amanita pantherina L., often in capsule form in sub-hallucinogenic doses. The availability of fly agarics and the variability of their ibotenic acid and muscimol content are contributing factors to acute poisoning.

The aim of this study is the botanical identification of dried raw materials of red and panther fly agaric and dried crushed contents of capsules for subsequent laboratory diagnosis of fly agaric poisoning.

Material and methods. For identification, samples of dried fruiting caps of A. muscaria L. and A. pantherina L. (FUNGITHERA mushroom pharmacy) and powdered fruiting body capsules of A. muscaria (Die Familie) and A. pantherina (ALTAI ECO) were collected. Identification was performed using a Mikromed-1 microscope at ×100 and ×400 magnification.

Results and discussion. It has been established that, based on macroscopic and microscopic analysis, the authenticity of the caps of the fruiting bodies of the panther and red fly agaric and the powder of the fruiting bodies in capsules has been confirmed.

Conclusion. The results of a chromatographic study of extracts from Amanita muscaria and Amanita pantherina mushrooms and capsules were supplemented by botanical analysis. Based on macroscopic and microscopic analysis, the authenticity of the Amanita pantherina fruiting body caps and the fruiting body powder in capsules was confirmed.

The obtained botanical data will allow the capsule extracts to be used as reference samples in developing a method for identifying target toxicants in biological samples for laboratory diagnosis of poisoning by these mushrooms. This is particularly important, as commercially available standard samples of muscarine and muscimol are unavailable.

Farmaciya (Pharmacy). 2025;74(8):14-20
pages 14-20 views
Development and validation of analytical methods for pharmaceutical ingredient and dosage form of 6,8-dimethyl-2-(piperidinomethyl)-2,3-dihydrothiazolo[2,3-f]xanthine
Petrakov A.I., Krivoshchekov S.V., Klen E.E., Khaliullin F.A., Guryev A.M., Belousov M.V.
Abstract

Introduction. The development of a new drug based on 6,8-dimethyl-2-(piperidinomethyl)-2,3-dihydrothiazolo[2,3-f]xanthine, an inducer of hepatocyte monooxygenase system, requires mandatory development and validation of methods for its qualitative and quantitative determination.

Aim. To develop and validate the methods of qualitative and quantitative analysis of pharmaceutical ingredient and tablets of 6,8-dimethyl-2-(piperidinomethyl)-2,3-dihydrothiazolo[2,3-f]xanthine obtained by wet granulation method.

Material and methods. For developing methods of qualitative and quantitative analysis, high-performance liquid chromatography (HPLC) and infrared spectroscopy were used. Validation of authenticity identification method using IR spectroscopy was performed according to specificity criterion. The HPLC method for quantitative determination was validated with respect to linearity, accuracy, repeatability, and intermediate precision.

Results. When comparing IR spectra of 6,8-dimethyl-2-(piperidinomethyl)-2,3-dihydrothiazolo[2,3-f]xanthine, potassium bromide, and initial synthesis components, specific absorption maxima characteristic for the ingredient were determined at wavelengths: 744, 1388 cm-1. In setting up the HPLC method, trifluoroacetic acid with concentration of 10 g/l proved optimal as an acidic modifier in mobile phase (acetonitrile:aqueous acid solution). Using isopropyl alcohol mixed in ratio 1:10 reduced total analysis time down to 8 minutes.

Conclusion. Qualitative and quantitative analytical methods have been developed and validated for pharmaceutical ingredient and tablets containing 6,8-dimethyl-2-(piperidinomethyl)-2,3-dihydrothiazolo[2,3-f]xanthine.

Farmaciya (Pharmacy). 2025;74(8):21-30
pages 21-30 views
Bioavailability and cytotoxicity of dihydroquercetin – L-lysine compositions
Svotin A.A., Korochkina M.D., Kolesnikova D.R., Krivosheeva E.A., Terekhov R.P., Selivanova I.A.
Abstract

Introduction. Dihydroquercetin (DHQ) is a natural flavanonol with a high safety profile and various biological effects. Among these, anti-inflammatory and wound-healing properties stand out. However, one of the challenges in developing drugs based on DHQ is its limited solubility in water at room temperature, which affects its bioavailability. This makes it difficult for DHQ to be used in medicine.

Objective: to investigate the biopharmaceutical properties and cytotoxicity of DHQ compositions in combination with L-lysine.

Material and methods. To obtain DHQ compositions with L-lysine, the following steps were taken: first, the material was ground, then lyophilized or dried in an aqueous solution at 65°C. The solubility of the resulting product was assessed in accordance with the GPA.1.2.1.0005 of the Russian Federation State Pharmacopoeia XV and the EAEU Pharmacopoeia. A method for quantitative analysis of flavonoids in a mechanical mixture was developed based on UV-spectrophotometry. The bioavailability of the compound was assessed by its diffusion into agar, and its cytotoxic properties were tested on CaCo-2, 3T3, HUVEC, and HEK293 cell lines in experimental conditions using CCK-8.

Results. A mechanical mixture with significantly improved solubility compared to the original flavonoid was produced using the grinding method. The resulting compositions, in the form of lyophilizates and films, have similar solubility, classified as "very easily soluble" according to Russian Federation State Pharmacopoeia XV. A significant increase in bioavailability was observed as a result of these compositions. A method for quantifying flavonoids using UV-spectrophotometry was developed. When studying the cytotoxic properties of these objects, it was found that lyophilization reduced cytotoxicity, with IC50 values of 0.025, 0.068, 0.145 and 0.288 mg/ml for 3T3, HEK293, CaCo-2, and HUVEC cells, respectively.

Conclusion. The obtained modifications may be interesting from the point of view of increasing the bioavailability and solubility of natural flavonoids. This solves one of the main problems in the development of drug products based on these compounds.

Farmaciya (Pharmacy). 2025;74(8):31-39
pages 31-39 views
Development and validation of methods for the quantitative determination of dihydroquercetin-glycine lyophilizate components
Pankov D.I., Sukhova E.M., Terekhov R.P., Zhevlakova A.K., Selivanova I.A.
Abstract

Introduction. Herbal preparations occupy an important part in medical practice along with synthetic drugs. Flavonoids are the main group of biologically active substances in many of plant medicinal products. Flavonoids are generally slightly soluble in water. To overcome the low solubility, attempts are being made to obtain cocrystalline and coamorphic forms of flavonoids, for example, with amino acids. A neuroprotective effect has been established for both flavanonol dihydroquercetin and the amino acid glycine, which served as a starting point for obtaining a solid-phase product based on them by freeze drying.

The purpose of this work is to develop and validate methods for the identification and quantification of the two active ingredients of the dihydroquercetin-glycine composition.

Material and methods. Glycine was determined spectrophotometrically after reaction with ninhydrin. Dihydroquercetin analysis was performed using the HPLC-UV method on phenyl silica gel. The following validation characteristics were evaluated: accuracy, precision, specificity, linearity, and analytical range.

Results. The linear dependence of the optical density of Ruhemann's purple on the concentration of glycine is observed in the range of 0.1–0.5 mg/mL and obeys the equation A=5.1237C − 0.5553 (r=0.9968). The relative standard deviations of absorption according to the results of 3 determinations for concentrations of 80, 100, and 120% glycine are 3.2, 1.9, and 1.3%, respectively. The linear dependence of the area of the dihydroquercetin peak on its concentration is observed in the range of 10–200 μg/mL and obeys the equation S=121.518C – 47.935 (r=0.9998). The relative standard deviations of the peak area of the base substance according to the results of 3 determinations for concentrations of 10, 50, and 200 μg/mL of dihydroquercetin are 2.8, 3.9, and 1.2%, respectively.

Conclusion. The validated methods are suitable for pharmaceutical analysis and can be used in quality control of the composition, which is being developed as the basis of the dosage form “Lyophilizate for solution preparation for infusion”.

Farmaciya (Pharmacy). 2025;74(8):40-51
pages 40-51 views

Technology of medicines

Prospects and opportunities for pharmaceutical production specialists training
Mymrina A.L., Geller L.N., Tueva I.A., Chuchalin V.S.
Abstract

Introduction. The main trend toward localization of pharmaceutical production and growth of the pharmaceutical market increase the demand for specialists with competencies in drug development, manufacturing, quality control and circulation, including knowledge and skills related to the specific characteristics of drugs.

Objective: to present practical experience and possible ways to modernize educational programs and the training pathway for specialists for the pharmaceutical industry using the example of cooperation between the Faculty of Pharmacy of SibSMU (Tomsk), Novokuznetsk State Institute for Advanced Medical Education (a branch of RMANPO, Novokuznetsk), and the drug manufacturer JSC “Organica” (Novokuznetsk).

Material and methods. Content analysis of higher education and continuing professional education curricula in Pharmacy, analysis of the demand of a pharmaceutical manufacturer for pharmacist competencies, and interviewing 69 pharmacists from healthcare institutions and private pharmacies in the Kemerovo Region.

Results. Most pharmacists reported dissatisfaction with their current occupational functions and limited use of fundamental knowledge in practice, demonstrated interest in industrial pharmacy and readiness to undertake advanced training and move to pharmaceutical manufacturing while maintaining their accreditation status. The information obtained allows us to review training and professional development programs for pharmacists in terms of their focus on industrial pharmacy, quality management, pharmacovigilance, and marketing support for pharmaceutical drugs.

Conclusion. Expanding the list of competencies developed within classical pharmaceutical education and including modules focused on industrial pharmacy broadens the scope of practical application of the pharmacist qualification and increases its demand in industrial pharmacy.

Farmaciya (Pharmacy). 2025;74(8):52-55
pages 52-55 views
Development of a film for the treatment of open soft tissue injuries
Avtina N.V., Prasolova A.V., Zhilyakova E.T., Blinova A.A., Sokulskaya N.N., Andrusenko S.F.
Abstract

Introduction. Applicational dosage forms, particularly films, are a practical and convenient form of treatment for wounds on the skin and mucous membranes, keloids, and scars. It should be noted that film-based medications are currently limited on the Russian pharmaceutical market. Therefore, research into the composition and technology of these film-based medications is essential. The study utilized a comprehensive approach, including the pharmaceutical development of films for application to wound surfaces of the skin and mucous membranes, as well as an examination of the factors determining the success of the final product. The results will allow, among other things, the formulation of recommendations for the structure and content of the temporary pharmacopoeial monograph “Applicational dosage forms intended for application to wound surfaces”.

Objective. Development of an optimal composition and justification of the technology of a wound-healing application dosage form – a film containing snail mucin and zinc oxide nanoparticles as active ingredients.

Material and methods. During the development of the dosage form, the study subjects were drug substances and excipients that meet the requirements of regulatory documentation. To achieve the study objective, a series of tests were applied (“Description”, “Film dimensions”, “Mass homogeneity”, “Solution pH”, “Disintegration”, “Mass loss on drying or Water”) corresponding to OFS.1.4.1.0035 “Films”. The choice of carrier matrix for the pharmacologically active substances was substantiated by studying their organoleptic and pharmaceutical-technological characteristics. Tensile testing of the films was conducted in accordance with GOST 14236-81 “Polymer films. Tensile testing method”. The reliability of the study results was assessed using mathematical and statistical methods.

Results. An analysis of the range of medicinal products registered in the State Register of Medicinal Products (GRLS) in the form of films was conducted. It was established that five medicinal products produced in the form of films are sold in the Russian Federation - two variants of “Trinitrolong”, “Devatorin” or “Notaspazm”, “Individa ODP”, “Taurine”. A composition of a multicomponent film with snail mucin and nanosized zinc oxide was developed. Tests were carried out in accordance with OFS.1.4.1.0035 “Films” and GOST 14236-81 “Polymer films. Tensile test method”. Optimal polymer carriers of snail mucin and nanosized zinc oxide for the manufacture of films were determined: composition No.3, containing Na-carboxymethyl cellulose; Compositions No.4 and No.10, containing Na-carboxymethylcellulose and polyvinyl alcohol in a ratio of 2:1; composition No.2, containing methylcellulose and polyvinyl alcohol in a ratio of 2:1. An optimal technological scheme for producing films that meet the requirements of regulatory documentation is presented, using the example of films with snail mucin and zinc oxide nanoparticles based on sodium carboxymethylcellulose with polyvinyl alcohol.

Conclusion. The results of the conducted research made it possible to develop the composition and technology of an application dosage form in the form of a film with snail mucin and zinc oxide nanoparticles.

Farmaciya (Pharmacy). 2025;74(8):56-65
pages 56-65 views

Pharmacology: Experiment and clinic

Study of the antiallergic activity of the liquid extract «Phytoeczemaderm»
Imamaliev B.A.
Abstract

Introduction. The antiallergic activity of the phytospecies «Phytoeczemaderm» recommended for topical therapy of eczema was studied.

Material and methods. The study of antiallergic activity was carried out on a model of allergic contact dermatitis caused by skin application of turpentine. As reference preparation were used: antihistamine preparation «Diphenhydramine» gel 1%; glucocorticoid preparation (topical steroid) «Clobetasol» cream 0,05%; zinc preparation «Zinc ointment 10%».

Results. During the experiment, it was found, that the test preparation has a reliable antiallergic activity, which is reliably manifested in a decrease in the total allergic reaction, in a reduction in recovery time and in a decrease in the dynamics of the severity of allergic reactions. Also, the study of antiallergic activity showed, that the test preparation has a comparable antiallergic activity with reference synthetic preparation.

Conclusion. The foregoing indicates the presence of a reliable antiallergic activity in the «Phytoeczemaderm» preparation, which is comparable to reference synthetic preparations.

Farmaciya (Pharmacy). 2025;74(8):66-73
pages 66-73 views

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».